Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections

Post time 2024-4-29 12:09:14

journal：Clinical Microbiology and Infection

Authors：Joshua Osowicki; Fergus Hamilton; Todd C. Lee; Michael Marks; Erin K. McCreary; Emily G. McDonald; Jonathan H. Ryder; Steven Y.C. Tong

Published date：2024-5-

DOI：10.1016/j.cmi.2024.02.001

PDF link：https://www.sciencedirect.com/sc ... 198743X24000570/pdf

Article link：http://dx.doi.org/10.1016/j.cmi.2024.02.001

Article Source：Elsevier BV。

Remark：

Post time 2024-4-29 12:09:15

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections